Afya (NASDAQ:AFYA) Stock Rating Upgraded by Zacks Research

Afya (NASDAQ:AFYA) was upgraded by Zacks Research from a “strong sell” rating to a “hold” rating in a note issued to investors on Monday,Zacks.com reports.

Several other research firms have also weighed in on AFYA. Wall Street Zen lowered Afya from a “strong-buy” rating to a “buy” rating in a report on Saturday, January 31st. Sanford C. Bernstein upgraded shares of Afya to a “market perform” rating in a research report on Friday, January 16th. Bank of America cut shares of Afya from a “buy” rating to a “neutral” rating and lowered their price objective for the company from $22.00 to $17.00 in a research note on Tuesday, February 24th. UBS Group restated a “neutral” rating and set a $16.00 target price (down from $18.00) on shares of Afya in a research report on Friday, January 16th. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Afya in a research report on Wednesday, January 21st. One investment analyst has rated the stock with a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat, Afya currently has an average rating of “Hold” and a consensus price target of $17.30.

Afya Price Performance

Shares of NASDAQ:AFYA opened at $14.04 on Monday. The firm has a market capitalization of $1.32 billion, a price-to-earnings ratio of 10.10, a price-to-earnings-growth ratio of 0.63 and a beta of 0.52. The company has a debt-to-equity ratio of 0.21, a current ratio of 0.98 and a quick ratio of 0.98. The business’s 50 day simple moving average is $14.49 and its 200-day simple moving average is $14.79. Afya has a 12 month low of $13.00 and a 12 month high of $19.90.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. Goldman Sachs Group Inc. boosted its position in shares of Afya by 167.3% in the first quarter. Goldman Sachs Group Inc. now owns 45,093 shares of the company’s stock worth $809,000 after acquiring an additional 28,226 shares during the last quarter. Campbell & CO Investment Adviser LLC increased its position in Afya by 31.5% during the second quarter. Campbell & CO Investment Adviser LLC now owns 51,340 shares of the company’s stock worth $917,000 after purchasing an additional 12,286 shares during the last quarter. Geode Capital Management LLC raised its stake in Afya by 85.1% during the second quarter. Geode Capital Management LLC now owns 52,111 shares of the company’s stock worth $931,000 after purchasing an additional 23,961 shares during the period. Dynamic Technology Lab Private Ltd acquired a new position in shares of Afya in the 2nd quarter valued at $391,000. Finally, Quadrature Capital Ltd purchased a new stake in Afya during the second quarter valued at about $181,000. Institutional investors and hedge funds own 88.02% of the company’s stock.

About Afya

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.